Clinical Trial Update: Phase II Study to Evaluate the Efficacy of AMG 317 [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating AMG 317 for asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AMG 317

Snippet

Sponsor: Amgen | Conditions: Asthma | Phase 2 | Status: COMPLETED